10:55 AM EDT, 08/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our 12-month target price by $3 to $85, valuing MET shares at 8.4x our '26 operating EPS estimate of $10.15 (lowered today by $0.25), versus the shares' 1YR average forward multiple of 8.6x and a peer average of 9.2x. We also lower our '25 EPS estimate by $0.45 to $8.75 after MET posted Q2 EPS of $2.02 (versus $2.28), which lagged our $2.37 EPS estimate and the $2.16 consensus view. These results reflect a 1.8% decline in operating revenues (lagging our 4% to 8% forecasted rise) on a 6% drop in premiums and 9% higher investment income. The drop in premium and fee revenues largely reflected a decline in pension risk transfer (PRT) activity in the quarter. This highly transactional line of coverage aids MET's overall revenue growth prospects, albeit with a degree of volatility and uncertainty, in our view. To that end, premium and fee revenues excluding the PRT business grew by 5% Y/Y in Q2 2025. We now see flat to 5% growth in operating revenues in '25, though a large PRT transaction could alter that trajectory. While this lack of visibility tempers our outlook, we still view MET as an undervalued franchise.